Skip to content

The Impact of a Multidisciplinary Treatment Approach on Health Outcomes in Lung Cancer Patients: A Single-Center, Prospective Cohort Study

The Impact of a Multidisciplinary Treatment Approach on Health Outcomes in Lung Cancer Patients: A Single-Center, Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099504
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Single-specialty physician prescribed treatment plan group:None
Multidisciplinary team (MDT) discussion to formulate personalized treatment plans group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Subjects voluntarily join this study, sign the informed consent form, and cooperate with the follow-up; 2. Lung cancer diagnosed by histology/cytology at the Lung Cancer Center of West China Hospital, Sichuan University (according to AJCC 9th edition); 3. Age>=18 years old, male or female; 4. Plan to receive anti-tumor therapy and be able to provide informed consent; 5. The MDT group has undergone at least one MDT discussion; 6. Estimated survival >=3 months; 7. The subjects had good compliance and cooperated with follow-up.

Exclusion criteria

Exclusion criteria: 1. Combined with other tumors; 2. Those who have a history of psychotropic drug abuse and cannot be quit or have mental disorders; 3. As judged by the investigator, the subject has other factors that may lead to the forced termination of the study, such as other serious diseases (including mental illnesses) that require concurrent treatment, serious abnormal laboratory test values, family or social factors, and it is difficult to follow up for a long time; 4. Other conditions judged by the investigator to be unsuitable for inclusion in this study (only receiving palliative treatment, etc.).

Design outcomes

Primary

MeasureTime frame
2-year overall survival rate;

Secondary

MeasureTime frame
Quality of Life Score;Patient Satisfaction Evaluation;1-year survival;5-year survival;Median Progression-Free Survival;Incidence of Treatment-Emergent Adverse Events;

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital, Sichuan University

cheguoweixw@126.com+86 189 8060 1890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026